From persistent dry eyes to unexpected complications – what experts say you should know before undergoing Lasik surgery.

Cyclosporine 0.09% significantly improves CFS scores and tear production in patients with uncontrolled dry eye disease, including those with MGD. Scleral lenses offer a non-surgical intervention ...

LONDON and NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic ...

Urcosimod has demonstrated statistical significance in key endpoints during clinical trials, indicating its potential effectiveness for treating both dry eye disease and neuropathic corneal pain.

Urcosimod has been shown to produce anti-inflammatory and pain-reducing activities in mouse models of dry eye disease and corneal neuropathic pain, respectively, and is designed to combat washout ...

Michelle Hessen, OD, discusses how cyclosporine ophthalmic solution 0.09% is safe to use in patients with dry eye, as well as where future research should turn.

An eye exam can detect hidden health issues like diabetes, hypertension, and even brain tumors, making regular checkups vital ...

“Showering in contacts is risky,” Dr. James Kelly, an ophthalmologist and founder of Kelly Vision, told HuffPost. “Tap water ...

Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...

It can be hard to tell a scratched cornea (corneal abrasion) from pink eye (also known as conjunctivitis) as they have similar symptoms, such as eye redness, tearing, and sensitivity to light. Though ...

OKYO Pharma has filed a Fast Track designation application for urcosimod in the treatment of neuropathic corneal pain.